June 4, 2002
ATI Airtest Technologies Inc. (CDNX Symbol AAT)
AIRTEST TO DEVELOP HOMELAND SECURITY MONITORS
[Vancouver British Columbia] Mr. George Graham the President of
ATI AirTest Technologies Inc. is pleased to announce the signing
of a letter of intent to enter into a business relationship with
MCL Technologies Corp. ("MCL") based in Albuquerque, New
MCL develops and manufactures "lab-on-a-chip" microsensor
modules for a number of commercial markets and for military-related
applications. MCL has obtained a license agreement with Sandia National
Laboratories that gives MCL the rights to commercial applications
for microsensor technology developed by Sandia.
In the proposed business relationship, MCL will sell chemical agent
microsensor modules to ATI for use in Homeland Security Monitors
that will be developed jointly by MCL and ATI. ATI will have the
exclusive right to utilize MCL microsensor modules in chemical agent
monitors for the commercial building and related HVAC equipment
market. ATI has also agreed to cooperate with both MCL and other
MCL partners in the development of MCL's technology.
The chemical agent monitors will be similar in design to the CO2
monitors currently being marketed by ATI. The primary application
for chemical agent monitors will be the installation of duct-mounted
models in the ventilation systems in highly populated or high security
Statements about the Company's future expectations and all other
statements in this press release other than historical facts are
"forward looking statements". The Company intends that
such forward-looking statements be subject to the safe harbours
created thereby. Since these statements involve risks and uncertainties
and are subject to change at any time, the Company's actual results
may differ materially from the expected results. The Canadian Venture
Exchange has not reviewed and does not accept responsibility for
the adequacy or accuracy of this release.
For further information, please contact:
Georgia West Management Inc.
Phone: (604) 868 1000
Toll Free: (877) 868 1001
The Canadian Venture Exchange has not reviewed and does not accept
responsibility for the adequacy or accuracy of this release.